Aurobindo Pharma buys Teva's calcium & vitamin D3 products in France

This acquisition will enable Aurobindo Pharma’s French arm to continue to increase its branded products portfolio and leverage its position as a key player in the drug market. Arrow Generiques is a pharmaceutical company with focus on selling generics on the retail and hospital markets in France since 2002. Arrow Generiques entered a strategy of diversification with the acquisition of the first branded products a few years ago to become a company balanced between generics, branded products & biosimilars on retail and hospital markets. A dedicated business unit with sales and marketing team had been set up to specifically enhance this business.

“Arrow Generiques has continued developing the brand awareness among prescribers through the promotion of mature products and the launch of specialties for patients care. The achievement of the medical visit certification confirms the company's strategy in medical promotion. This deal will boost the position of Arrow Generiques and open new opportunities for the future,” said Aurobindo Pharma in a press release.